Anti-HIV1 integrase抗体[IN-2] (ab66645)
Key features and details
- Mouse monoclonal [IN-2] to HIV1 integrase
- Suitable for: WB, ICC/IF, IP
- Reacts with: Human immunodeficiency virus
- Isotype: IgG1
概述
-
产品名称
Anti-HIV1 integrase抗体[IN-2] -
描述
小鼠单克隆抗体[IN-2] to HIV1 integrase -
宿主
Mouse -
特异性
ab66645 is specific for bacterial HIV1 integrase (IN) protein. -
经测试应用
适用于: WB, ICC/IF, IPmore details -
种属反应性
与反应: Human immunodeficiency virus -
免疫原
Recombinant full length protein corresponding to HIV1 integrase. Bacterially expressed, hexahistidine amino-terminal tagged HIV1 integrase (IN) protein (clade B, HXB-3 isolate)
-
常规说明
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
存储溶液
Preservative: 0.1% Sodium azide
Constituent: PBS -
Concentration information loading...
-
纯度
Protein G purified -
克隆
单克隆 -
克隆编号
IN-2 -
骨髓瘤
Sp2/0 -
同种型
IgG1 -
轻链类型
kappa -
研究领域
相关产品
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab66645于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
WB | (1) |
1/2000. Predicted molecular weight: 32 kDa.
|
ICC/IF | (1) |
Use at an assay dependent dilution.
|
IP | (1) |
Use at an assay dependent dilution.
|
说明 |
---|
WB
1/2000. Predicted molecular weight: 32 kDa. |
ICC/IF
Use at an assay dependent dilution. |
IP
Use at an assay dependent dilution. |
靶标
-
相关性
Integrase is an enzyme, a product of the HIV1 Gag/Pol gene; the other two enzymes being reverse transcriptase and protease. The human immunodeficiency virus (HIV-1) uses an enzyme, a so-called integrase, to carry out the integration of its viral DNA into the host chromosome thereby tricking the host cell machinery into making viral proteins. The HIV-1 integrase is a protein of 32 kDa and is composed of three domains. No cellular homologue of HIV integrase has been described, so potential inhibitors to this enzyme could be relatively nontoxic. -
数据库链接
- Entrez Gene: 155348 Human immunodeficiency virus
- SwissProt: P04585 Human immunodeficiency virus
- SwissProt: Q76353 Human immunodeficiency virus
-
别名
- HIV antibody
- Human Immunodeficiency virus 1 antibody
- IN antibody
- Integrase antibody
图片
-
ab66645 staining HIV1 integrase in transfected 293T by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with methanol/acetone (1:1), permeabilized with 0.1% Triton X-100 and blocked with 3% BSA for 1 hour at 22°C. Samples were incubated with primary antibody (1/1000 in PBS + 1% BSA) for 1 hour at 21°C. An Alexa Fluor® 555-conjugated Goat anti-mouse IgG polyclonal was used as the secondary antibody (1/2000).
实验方案
数据表及文件
-
SDS download
-
Datasheet download
文献 (12)
ab66645 被引用在 12 文献中.
- Chia T et al. A Small Molecule, ACAi-028, with Anti-HIV-1 Activity Targets a Novel Hydrophobic Pocket on HIV-1 Capsid. Antimicrob Agents Chemother 65:e0103921 (2021). PubMed: 34228546
- Imamichi T et al. Natural Occurring Polymorphisms in HIV-1 Integrase and RNase H Regulate Viral Release and Autoprocessing. J Virol 95:e0132321 (2021). PubMed: 34523971
- Zurnic Bönisch I et al. Capsid-Labelled HIV To Investigate the Role of Capsid during Nuclear Import and Integration. J Virol 94:N/A (2020). PubMed: 31941774
- Nakamura T et al. A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase Inhibitor. J Virol 94:N/A (2020). PubMed: 32611758
- Winans S & Goff SP Mutations altering acetylated residues in the CTD of HIV-1 integrase cause defects in proviral transcription at early times after integration of viral DNA. PLoS Pathog 16:e1009147 (2020). PubMed: 33351861